A genetically modified tumor-infiltrating lymphocytes product (GT202) exhibits enhanced persistence and anti-tumor efficacy against solid tumor in vivo

被引：0
|
作者：
Sun, Jingwei [1 ]
Jin, Jiahui [1 ]
Tan, Yongchao [1 ]
Chen, Lingyun [1 ]
Wang, Quanwei [1 ]
Liu, Yarong [1 ]
机构：
[1] Grit Biotechnol, Shanghai, Peoples R China
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5581
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo
    Maohua Li
    Rongqing Zhao
    Jianxin Chen
    Wenzhi Tian
    Chenxi Xia
    Xudong Liu
    Yingzi Li
    Song Li
    Hunter Sun
    Tong Shen
    Wenlin Ren
    Le Sun
    Scientific Reports, 11
  • [42] Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo
    Li, Maohua
    Zhao, Rongqing
    Chen, Jianxin
    Tian, Wenzhi
    Xia, Chenxi
    Liu, Xudong
    Li, Yingzi
    Li, Song
    Sun, Hunter
    Shen, Tong
    Ren, Wenlin
    Sun, Le
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [43] Enhanced anti-tumor efficacy of electroporation (EP)-mediated DNA vaccine boosted by allogeneic lymphocytes in pre-established tumor models
    Shi, Sanyuan
    Zhang, Luchen
    Zheng, Anjie
    Xie, Fang
    Kesse, Samuel
    Yang, Yang
    Peng, Jinliang
    Xu, Yuhong
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (12)
  • [44] β3-adrenergic receptor on tumor-infiltrating lymphocytes sustains IFN-γ-dependent PD-L1 expression and impairs anti-tumor immunity in neuroblastoma
    Bruno, Gennaro
    Nastasi, Nicoletta
    Subbiani, Angela
    Boaretto, Alessia
    Mannurita, Sara Ciullini
    Mattei, Gianluca
    Nardini, Patrizia
    Della Bella, Chiara
    Magi, Alberto
    Pini, Alessandro
    De Marco, Emanuela
    Tondo, Annalisa
    Favre, Claudio
    Calvani, Maura
    CANCER GENE THERAPY, 2023, 30 (06) : 890 - 904
  • [45] β3-adrenergic receptor on tumor-infiltrating lymphocytes sustains IFN-γ-dependent PD-L1 expression and impairs anti-tumor immunity in neuroblastoma
    Gennaro Bruno
    Nicoletta Nastasi
    Angela Subbiani
    Alessia Boaretto
    Sara Ciullini Mannurita
    Gianluca Mattei
    Patrizia Nardini
    Chiara Della Bella
    Alberto Magi
    Alessandro Pini
    Emanuela De Marco
    Annalisa Tondo
    Claudio Favre
    Maura Calvani
    Cancer Gene Therapy, 2023, 30 : 890 - 904
  • [46] The Novel Tubulin Polymerization Inhibitor MHPT Exhibits Selective Anti-Tumor Activity against Rhabdomyosarcoma In Vitro and In Vivo
    Mu, Yan
    Liu, Yin
    Li, Liwen
    Tian, Cong
    Zhou, Hongyu
    Zhang, Qiu
    Yan, Bing
    PLOS ONE, 2015, 10 (03):
  • [47] In vivo distribution characteristics and anti-tumor effects of doxorubicin encapsulated in PEG-modified niosomes in solid tumor-bearing mice
    Shehata, Tamer
    Higaki, Kazutaka
    Kimura, Toshikiro
    Ogawara, Ken-ichi
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 80
  • [48] Tumor-Infiltrating Lymphocytes, CAR-, and T-Cell Receptor-Modified T Cells in Solid Cancer Oncology
    Echchannaoui, Hakim
    Legscha, Kevin Jan
    Theobald, Matthias
    ONCOLOGY RESEARCH AND TREATMENT, 2025,
  • [49] Recombinant human IL-12 promotes the anti-tumor activity of human tumor-infiltrating lymphocytes (TIL) through the induction of IFN-γ and iNOS in a human tumor/TIL scid mouse xenograft model
    Hess, SD
    Egilmez, NK
    Jong, YS
    Chen, FA
    Anderson, TM
    Mathiowitz, E
    Bankert, RB
    FASEB JOURNAL, 2000, 14 (06): : A1007 - A1007
  • [50] In vivo anti-tumor activity of genetically modified T cells is dependent on the method of ex vivo T cell expansion.
    Brentjens, RJ
    Latouche, JB
    Riviere, I
    Sadelain, M
    BLOOD, 2002, 100 (11) : 577A - 577A
12345